Brain Cancer Clinical Trials

Showing 881-900 of 1,242 trials

COMPLETEDPhase 2

An Efficacy Study Of Ortataxel In Recurrent Glioblastoma

NCT01989884

Italian Study On The Efficacy Of Ortataxel In Recurrent Glioblastoma

Glioblastoma

Mario Negri Institute for Pharmacological Research45 participantsStarted Nov 2013

Lecco, Italy • Milan, Italy • Milan, Italy +4 more locations

COMPLETEDPhase 1/2

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

NCT00049127

This phase I/II trial is studying the side effects and best dose of imatinib mesylate and to see how well it works in treating patients with a recurrent brain tumor that has not responded to previous surgery and radiation therapy. Imatinib mesylate may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.

Adult Anaplastic OligodendrogliomaAdult Mixed GliomaAdult Oligodendroglioma+1 more

Alliance for Clinical Trials in Oncology64 participantsStarted Jun 2003

Scottsdale, Arizona, United States • Hartford, Connecticut, United States • Jacksonville, Florida, United States +226 more locations

An Efficacy Study Of Ortataxel In Recurrent Glioblastoma

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Related Searches

Role of Fibirnogen Like Protein 2 as Aprognostic Factor in High Grade Glioma

Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors

Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide

Radionecrosis and FDG PET

Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R

Radiation Therapy in Treating Young Patients With Gliomas

Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy

A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers

TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM

Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab

Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)

Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM